Correction to: Stability and Safety of an AAV Vector for Treating RPGR-ORF15X-Linked Retinitis Pigmentosa by Deng, W.-T. et al. Hum Gene Ther 2015;26(9):593–602. DOI: 10.1089/hum.2015.035);Stability and Safety of an AAV Vector for Treating RPGR-ORF15 X-Linked Retinitis Pigmentosa

Human Gene Therapy

Volumn 26, Issue 9, 2015, Pages 593-602

  Deng, Wen Tao ^a   Dyka, Frank M ^a   Dinculescu, Astra ^a   Li, Jie ^a   Zhu, Ping ^a   Chiodo, Vince A ^a   Boye, Sanford L ^a   Conlon, Thomas J ^b   Erger, Kirsten ^b   Cossette, Travis ^b   Hauswirth, William W ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AAV VECTOR; COMPLEMENTARY DNA; PROTEIN; PURINE NUCLEOTIDE; RPGR ORF15 PROTEIN; UNCLASSIFIED DRUG; VIRUS VECTOR; EYE PROTEIN; RPGR PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANINE MODEL; CONTROLLED STUDY; DNA SEQUENCE; ELECTRORETINOGRAPHY; GENE REPLACEMENT THERAPY; GENETIC VARIABILITY; HISTOLOGY; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PROTEIN EXPRESSION; RETINITIS PIGMENTOSA; SAFETY; VIRAL GENE THERAPY; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; DEPENDOPARVOVIRUS; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; MALE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PATHOLOGY; RETINA;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; DEPENDOVIRUS; EYE PROTEINS; GENETIC THERAPY; GENETIC VECTORS; HUMANS; MALE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; RETINA;

EID: 84941269728     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2015.035.correx     Document Type: Erratum

References (38)

1. Daiger SP, Bowne SJ, Sullivan LS. Perspective on genes and mutations causing retinitis pigmentosa. Arch Ophthalmol 2007;125:151-158.
2. Rattner A, Sun H, Nathans J. Molecular genetics of human retinal disease. Annu Rev Genet 1999;33:89-131.
3. Bird AC. X-linked retinitis pigmentosa. Br J Ophthalmol 1975;59:177-199.
4. Breuer DK, Yashar BM, Filippova E, et al. A comprehensive mutation analysis of RP2 and RPGR in a North American cohort of families with X-linked retinitis pigmentosa. Am J Hum Genet 2002;70:1545-1554.
5. Vervoort R, Lennon A, Bird AC, et al. Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa. Nat Genet 2000;25:462-466.
6. Jacobson SG, Buraczynska M, Milam AH, et al. Disease expression in X-linked retinitis pigmentosa caused by a putative null mutation in the RPGR gene. Invest Ophthalmol Vis Sci 1997;38: 1983-1997.
7. Sandberg MA, Rosner B, Weigel-DiFranco C, et al. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations. Invest Ophthalmol Vis Sci 2007;48:1298-1304.
8. Aleman TS, Cideciyan AV, Sumaroka A, et al. Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutations. Invest Ophthalmol Vis Sci 2007;48:4759-4765.
9. Andreasson S, Ponjavic V, Abrahamson M, et al. Phenotypes in three Swedish families with Xlinked retinitis pigmentosa caused by different mutations in the RPGR gene. Am J Ophthalmol 1997;124:95-102.
10. Weleber RG, Butler NS, Murphey WH, et al. Xlinked retinitis pigmentosa associated with a 2-base pair insertion in codon 99 of the RP3 gene RPGR. Arch Ophthalmol 1997;115:1429-1435.
11. Hong DH, Li T. Complex expression pattern of RPGR reveals a role for purine-rich exonic splicing enhancers. Invest Ophthalmol Vis Sci 2002;43: 3373-3382.
12. Hong DH, Pawlyk BS, Shang J, et al. A retinitis pigmentosa GTPase regulator (RPGR)-deficient mouse model for X-linked retinitis pigmentosa (RP3). Proc Natl Acad Sci USA 2000;97:3649-3654.
13. Kirschner R, Rosenberg T, Schultz-Heienbrok R, et al. RPGR transcription studies in mouse and human tissues reveal a retina-specific isoform that is disrupted in a patient with X-linked retinitis pigmentosa. Hum Mol Genet 1999;8:1571-1578.
14. Yan D, Swain PK, Breuer D, et al. Biochemical characterization and subcellular localization of the mouse retinitis pigmentosa GTPase regulator (mRpgr). J Biol Chem 1998;273:19656-19663.
15. Khanna H, Hurd TW, Lillo C, et al. RPGR-ORF15, which is mutated in retinitis pigmentosa, associates with SMC1, SMC3, and microtubule transport proteins. J Biol Chem 2005;280:33580-33587.
16. Shu X, Fry AM, Tulloch B, et al. RPGR ORF15 isoform co-localizes with RPGRIP1 at centrioles and basal bodies and interacts with nucleophosmin. Hum Mol Genet 2005;14:1183-1197.
17. Thompson DA, Khan NW, Othman MI, et al. Rd9 is a naturally occurring mouse model of a common form of retinitis pigmentosa caused by mutations in RPGR-ORF15. PLoS One 2012;7:e35865.
18. Brunner S, Skosyrski S, Kirschner-Schwabe R, et al. Cone versus rod disease in a mutant Rpgr mouse caused by different genetic backgrounds. Invest Ophthalmol Vis Sci 2010;51:1106-1115.
19. Hong DH, Pawlyk BS, Adamian M, et al. Dominant, gain-of-function mutant produced by truncation of RPGR. Invest Ophthalmol Vis Sci 2004;45:36-41.
20. Huang WC, Wright AF, Roman AJ, et al. RPGRassociated retinal degeneration in human X-linked RP and a murine model. Invest Ophthalmol Vis Sci 2012;53:5594-5608.
21. Zhang Q, Acland GM, Wu WX, et al. Different RPGR exon ORF15 mutations in Canids provide insights into photoreceptor cell degeneration. Hum Mol Genet 2002;11:993-1003.
22. Beltran WA, Cideciyan AV, Lewin AS, et al. Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa. Proc Natl Acad Sci USA 2012;109:2132-2137.
23. Shu X, Black GC, Rice JM, et al. RPGR mutation analysis and disease: an update. Hum Mutat 2007;28:322-328.
24. Wu Z, Hiriyanna S, Qian H, et al. A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration. Hum Mol Genet 2015 [Epub ahead of print].
25. Zolotukhin S, Byrne BJ, Mason E, et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 1999;6:973-985.
26. Pang JJ, Chang B, Kumar A, et al. Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis. Mol Ther 2006;13:565-572.
27. Li J, Samulski RJ, Xiao X. Role for highly regulated rep gene expression in adeno-associated virus vector production. J Virol 1997;71:5236-5243.
28. Berns KI, Adler S. Separation of two types of adeno-associated virus particles containing complementary polynucleotide chains. J Virol 1972; 9:394-396.
29. Ferrari FK, Samulski T, Shenk T, et al. Secondstrand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol 1996;70:3227-3234.
30. Nakai H, Storm TA, Kay MA. Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo. J Virol 2000;74:9451-9463.
31. He S, Parapuram SK, Hurd TW, et al. Retinitis pigmentosa GTPase regulator (RPGR) protein isoforms in mammalian retina: insights into X-linked retinitis pigmentosa and associated ciliopathies. Vis Res 2008;48:366-376.
32. Pang JJ, Deng WT, Dai X, et al. AAV-mediated cone rescue in a naturally occurring mouse model of CNGA3-achromatopsia. PLoS One 2012;7:e35250.
33. Timmers AM, Zhang H, Squitieri A, et al. Subretinal injections in rodent eyes: effects on electrophysiology and histology of rat retina. Mol Vis 2001;7:131-137.
34. Bader I, Brandau O, Achatz H, et al. X-linked retinitis pigmentosa: RPGR mutations in most families with definite X linkage and clustering of mutations in a short sequence stretch of exon ORF15. Invest Ophthalmol Vis Sci 2003;44:1458-1463.
35. Neidhardt J, Glaus E, Lorenz B, et al. Identification of novel mutations in X-linked retinitis pigmentosa families and implications for diagnostic testing. Mol Vis 2008;14:1081-1093.
36. Pusch CM, Broghammer M, Jurklies B, et al. Ten novel ORF15 mutations confirm mutational hot spot in the RPGR gene in European patients with X-linked retinitis pigmentosa. Hum Mutat 2002; 20:405.
37. Rozet JM, Perrault I, Gigarel N, et al. Dominant X linked retinitis pigmentosa is frequently accounted for by truncating mutations in exon ORF15 of the RPGR gene. J Med Genet 2002;39:284-285.
38. Hong DH, Pawlyk BS, Adamian M, et al. A single, abbreviated RPGR-ORF15 variant reconstitutes RPGR function in vivo. Invest Ophthalmol Vis Sci 2005;46:435-441.